🔗 Share this article

A shadow market for unapproved weight-loss drugs is being driven by TikTok fitness influencers and vendors on messaging platforms, based on new investigations.

Investigational Drug Gaining Traction Via Social Media

The experimental drug, which is still in research studies, is being promoted by online personalities for its alleged fat-burning properties. Viewers are urged to contact these profiles directly for supplier links, while also obtaining discount codes.

Active Trade on Messaging Platforms

Separately, a robust trade exists on Telegram, where groups with thousands of participants share “before and after” photos, injection guides and claims of rapid UK delivery. Vendors promote the drug there before redirecting customers to other platforms for transactions.

Understanding The Experimental Drug

This medication is an experimental injection created by American pharmaceutical company Eli Lilly. The drug affects three intestinal hormones – GLP-1, GIP and pancreatic hormone. Preliminary studies indicate it could help individuals lose up to a quarter of their total weight. Referred to as the “triple G”, the drug is being hailed online as the successor to Ozempic.

Medical Experts Express Concerns

However, physicians and chemists have warned that the distribution of what is still an unapproved drug in the UK is worrisome and could lead to individuals administering substances of uncertain source.

Some professionals stated the demand for the experimental drug could be connected to the rising cost of approved weight loss treatments such as Mounjaro.

Regulatory Position and Implementation

Selling the unapproved drug on social media or Telegram is prohibited in the United Kingdom, as it is an unapproved drug that cannot be marketed or distributed for personal consumption under the Human Medicines Regulations 2012.

Some influencers attempt to circumvent the rules by calling to the drug as a “research chemical” or describing it as “not for human consumption”. Retatrutide is not a controlled substance, but promotion and distribution can still breach pharmaceutical, marketing, and consumer laws, risking fines, prosecution or imprisonment.

Platform Response and Material Elimination

According to TikTok, the service has removed violative material and banned associated keywords and query recommendations. The organization said it was committed to maintaining the platform safe and investing in enhancing compliance measures.

Digital Marketplace Activities

Investigations also found groups with up to 9,000 members marketing retatrutide using the platform's built-in search feature, which functions like a public directory. Typing “retatrutide” instantly displays channels with thousands of users, filled with photos of slimming results, glowing testimonials and step-by-step instructions for mixing or administering at home.

Within moments of joining one group, a seller shared WhatsApp details, where the majority of purchases occur. The seller provided an instruction manual and promised shipping within two days. When questioned whether the substance was authentic, one vendor responded: “You can’t be sure.” Another shared a photo of a supposed testing documentation. Not one asked about weight, health issues or previous experience.

Product Details and Costs

Within these groups, messages display dark colored parcels with Royal Mail labels, claiming to include new batches. One message stated: “It took eight of us to load them this morning.”

Buyers can select between dry substance containers, prepared at residence with sterile water, or pre-filled injectors typically sold at 160 pounds for 20 milligrams. When asked how long a pen should last, sellers give conflicting responses varying between a few weeks to “depends on your body”.

Platform Moderation and Security Actions

A spokesperson for the messaging service stated it actively moderated dangerous material on its service including material that promoted the “misuse of controlled medications”. The company noted that it eliminated “millions of pieces of harmful content each day”.

Healthcare Professional Warnings

“Individuals are injecting materials they cannot confirm. Although the science behind this drug is sound, these digital products may not include what they advertise,” said a pharmacy expert, the director of pharmaceutical services at a pharmacy service.

A medical professional of Asda Online Doctor linked the increase in demand to recent price rises for approved weight-loss medications such as Mounjaro. “With prices increasing, individuals are turning to social media. But counterfeit injections are highly risky. You cannot know what’s contained or whether the conditions they were produced in was sterile,” she explained.

Her team has already encountered individuals harmed by self-injection from unverified suppliers. “We recognize the frustration, but purchasing from messaging apps or WhatsApp is gambling with your health,” stated the doctor. “These substances could be impure or incorrectly dosed.”

Manufacturer Position

A representative from Eli Lilly stated the substance was in third stage clinical trials and had not been reviewed or authorized by any government authority anywhere in the world. “Consequently at this point no one can sell [it] for human use,” they explained, noting that any item “misleadingly claiming itself as a Lilly experimental product not yet authorized … may subject patients to possibly serious medical dangers”.